Halneuron®
非阿片类止痛药
演示文稿
American Pain Society 34th annual scientific meeting
May 13-16, 2015. Palm Springs, CA, USA
American Pain Society 34th annual scientific meeting
May 13-16, 2015. Palm Springs, CA, USA
Canadian Pain Society 36th annual scientific meeting
May 20-23, 2015. Charlottetown, PEI. Canada
American Academy of Pain Management 26th annual clinical meeting
September 17-20, 2015. Washington, DC, USA.
American Academy of Neurology 68th annual meeting
April 15-21, 2016. Vancouver, BC, Canada
IASP 16th World Congress on Pain
Sep 26-30, 2016. Yokohama, Japan.
International Association for the Study of Pain (IASP) World Congress on Pain
September 19-23, 2022. Toronto, Ontario, Canada.
13th Congress of the European Pain Federation (EFIC®)
September 20-22, 2023. Budapest, Hungary.
科学出版物
有 WEX 作者的出版物列表
Marcil J, Walczak JS, Guindon J, Ngoc AH, Lu S, Beaulieu P. Antinociceptive effects of tetrodotoxin (TTX) in rodents.
Br J Anaesth. 2006 Jun;96(6):761-8.
Hagen NA, Fisher KM, Lapointe B, du Souich P, Chary S, Moulin D, Sellers E, Ngoc AH; Canadian Tetrodotoxin Study Group. An open-label, multi-dose efficacy and safety study of intramuscular tetrodotoxin in patients with severe cancer-related pain.
J Pain Symptom Manage. 2007 Aug;34(2):171-82.
Guzmán A, Fernández de Henestrosa AR, Marín AP, Ho A, Borroto JI, Carasa I, Pritchard L. Evaluation of the genotoxic potential of the natural neurotoxin Tetrodotoxin (TTX) in a battery of in vitro and in vivo genotoxicity assays.
Mutat Res. 2007 Dec 1;634(1-2):14-24.
Hagen NA, du Souich P, Lapointe B, Ong-Lam M, Dubuc B, Walde D, Love R, Ngoc AH; Canadian Tetrodotoxin Study Group. Tetrodotoxin for moderate to severe cancer pain: a randomized, double blind, parallel design multicenter study.
J Pain Symptom Manage. 2008 Apr;35(4):420-9.
Hagen NA, Lapointe B, Ong-Lam M, Dubuc B, Walde D, Gagnon B, Love R, Goel R, Hawley P, Ngoc AH, du Souich P. A multicentre open-label safety and efficacy study of tetrodotoxin for cancer pain.
Curr Oncol. 2011 Jun;18(3):e109-16.
Berde CB, Athiraman U, Yahalom B, Zurakowski D, Corfas G, Bognet C. Tetrodotoxin-bupivacaine-epinephrine combinations for prolonged local anesthesia.
Mar Drugs. 2011 Dec;9(12):2717-28.
Hagen NA, Cantin L, Constant J, Haller T, Blaise G, Ong-Lam M, du Souich P, Korz W, Lapointe B. Tetrodotoxin for Moderate to Severe Cancer-Related Pain: A Multicentre, Randomized, Double-Blind, Placebo-Controlled, Parallel-Design Trial.
Pain Res Manag. 2017;2017:7212713.
Kavoosi M, O’Reilly TE, Kavoosi M, Chai P, Engel C, Korz W, Gallen CC, Lester RM. Safety, Tolerability, Pharmacokinetics, and Concentration-QTc Analysis of Tetrodotoxin: A Randomized, Dose Escalation Study in Healthy Adults.
Toxins (Basel). 2020 Aug 9;12(8):511.
Goldlust SA, Kavoosi M, Nezzer J, Kavoosi M, Korz W, Deck K. Tetrodotoxin for Chemotherapy-Induced Neuropathic Pain: A Randomized, Double-Blind, Placebo-Controlled, Parallel-Dose Finding Trial.
Toxins (Basel). 2021 Mar 25;13(4):235.
没有WEX 作者的出版物列表
Berde CB, Athiraman U, Yahalom B, Zurakowski D, Corfas G, Bognet C. Tetrodotoxin-bupivacaine-epinephrine combinations for prolonged local anesthesia.
Mar Drugs. 2011 Dec;9(12):2717-28.